🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
66.89
-1.71 (-2.49%)
At close: Nov 20, 2026, 4:00 PM EST
67.48
+0.59 (0.89%)
After-hours: Nov 20, 2026, 7:30 PM EST

Globus Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,1402,9392,5191,5681,023958.1
Revenue Growth
13.35%16.65%60.62%53.34%6.76%21.43%
Cost of Revenue
963.05938.35819.88476.52262.83239.22
Gross Profit
2,1772,0011,6991,092760.01718.88
Selling, General & Admin
1,1691,135977.48643.41432.12408.15
Research & Development
143.52146.94161.6124.0173.0297.35
Amortization of Goodwill & Intangibles
118.02118.19119.3751.0317.7418.53
Operating Expenses
1,4301,4001,258818.45522.87524.02
Operating Income
746.08600.27441.03273.51237.15194.86
Interest Expense
---4.19---
Interest & Investment Income
24.237.14-20.1314.239.3
Currency Exchange Gain (Loss)
-11.84-3.01-43.2914.26-1.02-1.42
Other Non Operating Income (Expenses)
2.833.412.21-2.147.243.36
EBT Excluding Unusual Items
761.3607.82395.76305.76257.6206.09
Merger & Restructuring Charges
-43.76-77.35-274.72-139.93-6.85-16.98
Gain (Loss) on Sale of Investments
-----5.39-2.78
Legal Settlements
-22.61-43.1-0.31-0.43-2.34-5.92
Other Unusual Items
4.46117.7----
Pretax Income
699.39605.07120.72165.39243.02180.41
Income Tax Expense
141.7667.217.7442.5252.8531.22
Net Income
557.64537.87102.98122.87190.17149.19
Net Income to Common
557.64537.87102.98122.87190.17149.19
Net Income Growth
31.59%422.28%-16.19%-35.39%27.47%45.86%
Shares Outstanding (Basic)
135135136113100101
Shares Outstanding (Diluted)
137137138115103104
Shares Change
-0.58%-0.58%20.27%11.68%-0.95%2.63%
EPS (Basic)
4.143.980.761.091.891.48
EPS (Diluted)
4.063.920.751.071.851.44
EPS Growth
31.85%422.67%-29.91%-42.16%28.47%42.57%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
766.55588.77405.21165.23104.42219.38
Free Cash Flow Per Share
5.594.302.941.441.022.12
Gross Margin
69.33%68.07%67.46%69.62%74.30%75.03%
Operating Margin
23.76%20.42%17.51%17.44%23.18%20.34%
Profit Margin
17.76%18.30%4.09%7.83%18.59%15.57%
Free Cash Flow Margin
24.41%20.03%16.08%10.53%10.21%22.90%
EBITDA
1,025877.11694.42419.03305.4264.73
EBITDA Margin
32.66%29.84%27.56%26.72%29.86%27.63%
D&A For EBITDA
279.22276.84253.39145.5368.2569.87
EBIT
746.08600.27441.03273.51237.15194.86
EBIT Margin
23.76%20.42%17.51%17.44%23.18%20.34%
Effective Tax Rate
20.27%11.11%14.69%25.71%21.75%17.30%
SEC Filings: 10-K · 10-Q